Skip to main content

Table 1 Demographics trend of prostate cancer in Korea from 2005 to 2014

From: National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database

Characteristic

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

Total (N)

3548

4313

5080

6225

6873

7262

8449

8825

8929

9092

Age (yr)

 Mean ± SD

70.3 ± 8.5

70.1 ± 8.5

70.0 ± 8.3

69.9 ± 8.3

69.9 ± 8.2

69.9 ± 8.3

70.0 ± 8.2

70.3 ± 8.3

70.1 ± 8.2

70.5 ± 8.3

 < 50

39 (1.1)

56 (1.3)

56 (1.1)

65 (1.0)

73 (1.1)

83 (1.1)

82 (1.0)

67 (0.8)

73 (0.8)

75 (0.8)

 50–64

809 (22.8)

992 (23.0)

1153 (22.7)

1446 (23.2)

1497 (21.8)

1607 (22.1)

1932 (22.9)

2017 (22.9)

2064 (23.1)

2006 (22.1)

 65–74

1585 (44.7)

1958 (45.4)

2379 (46.8)

2966 (47.6)

3333 (48.5)

3482 (47.9)

3939 (46.6)

3957 (44.8)

4072 (45.6)

4062 (44.7)

 ≥ 75

1115 (31.4)

1307 (30.3)

1492 (29.4)

1748 (28.1)

1970 (28.7)

2090 (28.8)

2496 (29.5)

2784 (31.5)

2720 (30.5)

2949 (32.4)

Residential area

 Metropolitan

2124 (59.9)

2521 (58.5)

2916 (57.4)

3613 (58.0)

4040 (58.8)

4223 (58.2)

4971 (58.8)

5193 (58.8)

5311 (59.5)

5150 (56.6)

 Urban

873 (24.6)

1074 (24.9)

1431 (28.2)

1695 (27.2)

1829 (26.6)

1954 (26.9)

2241 (26.5)

2278 (25.8)

2358 (26.4)

2515 (27.7)

 Rural

524 (14.8)

583 (13.5)

733 (14.4)

917 (14.7)

1004 (14.6)

1085 (14.9)

1234 (14.6)

1354 (15.3)

1238 (13.9)

1368 (15.0)

 Unknown

27 (0.8)

135 (3.1)

3 (0.0)

22 (0.2)

59 (0.6)

Income level, quintiles

 Below poverty line (lowest)

628 (17.7)

615 (14.3)

339 (6.7)

356 (5.7)

407 (5.9)

438 (6.0)

521 (6.2)

493 (5.6)

572 (6.4)

459 (5.0)

 I

326 (9.2)

451 (10.5)

571 (11.2)

673 (10.8)

808 (11.8)

863 (11.9)

967 (11.4)

975 (11.0)

1026 (11.5)

1103 (12.1)

 II

337 (9.5)

380 (8.8)

581 (11.4)

614 (9.9)

720 (10.5)

710 (9.8)

847 (10.0)

856 (9.7)

921 (10.3)

946 (10.4)

 III

396 (11.2)

501 (11.6)

731 (14.4)

832 (13.4)

918 (13.4)

994 (13.7)

1128 (13.4)

1215 (13.8)

1184 (13.3)

1228 (13.5)

 IV

631 (17.8)

763 (17.7)

925 (18.2)

1214 (19.5)

1240 (18.0)

1377 (19.0)

1621 (19.2)

1657 (18.8)

1724 (19.3)

1776 (19.5)

 V (highest)

1230 (34.7)

1603 (37.2)

1933 (38.1)

2536 (40.7)

2780 (40.4)

2880 (39.7)

3365 (39.8)

3629 (41.1)

3502 (39.2)

3580 (39.4)

Charlson comorbidity index

 Mean ± SD

3.9 ± 3.6

3.9 ± 3.4

3.8 ± 3.4

4.0 ± 3.5

4.2 ± 3.5

4.2 ± 3.4

4.2 ± 3.5

4.4 ± 3.5

4.4 ± 3.5

4.4 ± 3.6

 0

616 (17.4)

584 (13.5)

607 (11.9)

701 (11.3)

673 (9.8)

682 (9.4)

741 (8.8)

747 (8.5)

748 (8.4)

752 (8.3)

 1–2

1030 (29.0)

1394 (32.3)

1738 (34.2)

1984 (31.9)

2117 (30.8)

2256 (31.1)

2648 (31.3)

2551 (28.9)

2609 (29.2)

2648 (29.1)

 3–4

637 (18.0)

804 (18.6)

1073 (21.1)

1357 (21.8)

1586 (23.1)

1703 (23.5)

1966 (23.3)

1990 (22.5)

2067 (23.1)

2159 (23.7)

 ≥ 5

1265 (35.7)

1531 (35.5)

1662 (32.7)

2183 (35.1)

2497 (36.3)

2621 (36.1)

3094 (36.6)

3537 (40.1)

3505 (39.3)

3533 (38.9)

  1. SD Standard deviation